X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Panacea Biotech with - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs ALKEM LABORATORIES - Comparison Results

PANACEA BIOTECH    Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH ALKEM LABORATORIES PANACEA BIOTECH/
ALKEM LABORATORIES
 
P/E (TTM) x 145.3 - - View Chart
P/BV x 3.2 7.5 42.8% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 PANACEA BIOTECH   ALKEM LABORATORIES
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-14
ALKEM LABORATORIES
Mar-16
PANACEA BIOTECH/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1491,589 9.4%   
Low Rs821,232 6.7%   
Sales per share (Unadj.) Rs84.1417.5 20.2%  
Earnings per share (Unadj.) Rs-18.356.3 -32.5%  
Cash flow per share (Unadj.) Rs-6.764.7 -10.4%  
Dividends per share (Unadj.) Rs012.70 0.0%  
Dividend yield (eoy) %00.9 0.0%  
Book value per share (Unadj.) Rs83.7292.9 28.6%  
Shares outstanding (eoy) m61.25119.57 51.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.43.4 40.6%   
Avg P/E ratio x-6.325.1 -25.2%  
P/CF ratio (eoy) x-17.221.8 -79.1%  
Price / Book Value ratio x1.44.8 28.7%  
Dividend payout %022.6 0.0%   
Avg Mkt Cap Rs m7,074168,653 4.2%   
No. of employees `0002.8NA-   
Total wages/salary Rs m1,4499,171 15.8%   
Avg. sales/employee Rs Th1,874.1NM-  
Avg. wages/employee Rs Th527.0NM-  
Avg. net profit/employee Rs Th-407.7NM-  
INCOME DATA
Net Sales Rs m5,15449,915 10.3%  
Other income Rs m1001,645 6.1%   
Total revenues Rs m5,25451,561 10.2%   
Gross profit Rs m-7668,482 -9.0%  
Depreciation Rs m7111,006 70.7%   
Interest Rs m1,503671 224.1%   
Profit before tax Rs m-2,8818,451 -34.1%   
Minority Interest Rs m11-114 -9.5%   
Prior Period Items Rs m-60-   
Extraordinary Inc (Exp) Rs m1,7710-   
Tax Rs m171,606 1.0%   
Profit after tax Rs m-1,1216,731 -16.7%  
Gross profit margin %-14.917.0 -87.5%  
Effective tax rate %-0.619.0 -3.1%   
Net profit margin %-21.813.5 -161.3%  
BALANCE SHEET DATA
Current assets Rs m3,81027,062 14.1%   
Current liabilities Rs m8,36515,324 54.6%   
Net working cap to sales %-88.423.5 -375.9%  
Current ratio x0.51.8 25.8%  
Inventory Days Days15667 234.1%  
Debtors Days Days6741 162.9%  
Net fixed assets Rs m14,48012,610 114.8%   
Share capital Rs m61239 25.6%   
"Free" reserves Rs m90334,490 2.6%   
Net worth Rs m5,12735,027 14.6%   
Long term debt Rs m5,8321,212 481.3%   
Total assets Rs m19,43354,387 35.7%  
Interest coverage x-0.913.6 -6.7%   
Debt to equity ratio x1.10 3,288.2%  
Sales to assets ratio x0.30.9 28.9%   
Return on assets %2.013.6 14.4%  
Return on equity %-21.919.2 -113.8%  
Return on capital %3.624.9 14.6%  
Exports to sales %24.512.9 189.4%   
Imports to sales %10.23.1 330.0%   
Exports (fob) Rs m1,2646,461 19.6%   
Imports (cif) Rs m5251,540 34.1%   
Fx inflow Rs m1,5396,563 23.5%   
Fx outflow Rs m9423,012 31.3%   
Net fx Rs m5973,552 16.8%   
CASH FLOW
From Operations Rs m5997,259 8.3%  
From Investments Rs m-4381,864 -23.5%  
From Financial Activity Rs m-303-9,273 3.3%  
Net Cashflow Rs m-141-150 94.2%  

Share Holding

Indian Promoters % 74.5 66.9 111.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.6 33.1 1.8%  
FIIs % 1.3 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 23.6 0.0 -  
Shareholders   10,259 68,381 15.0%  
Pledged promoter(s) holding % 35.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   PFIZER  GSK PHARMA  FRESENIUS KABI ONCO.  WYETH LTD  ABBOTT INDIA  

Compare PANACEA BIOTECH With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PANACEA BIOTECH SHARE PRICE


Jan 19, 2018 (Close)

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH 5-YR ANALYSIS

COMPARE PANACEA BIOTECH WITH

MARKET STATS